摘要:
The aim of the present invention is to produce complexing agents of formula (I), in which a, b, c, Chrom 1 , Chrom 2 , Chrom 3 , R 3 , R 4 and R 5 are as defined in the description. The invention also concerns lanthanide complexes comprising said complexing agents, as well as a method for synthesising said agents.
摘要:
The invention relates to complexing agents of formula (I), in which A1, A2, A3 and R1 are as defined in the description. The invention likewise relates to lanthanide complexes obtained from said complexing agents. The invention can be used for marking biological molecules.
摘要:
The invention relates to a method that makes it possible to predetermine if a compound to be tested preferably binds to a membrane receptor R1 or to a membrane receptor R2, said receptors being known to be expressed as a monomeric, homodimeric, or heterodimeric receptor on the surface of cells. Said method is implemented through the use of one or two FRET partner pairs.
摘要:
The invention relates to a method for selecting compounds having a modulating effect on the activation state of a dimer of VFT domain proteins expressed in cellular membranes in a measuring medium, said dimer including a first protein and a second protein which are identical or different, wherein the method includes the following steps: (a) marking the first and second proteins in the N-terminal portion of the VFT domain by members of a FRET partner pair, the Förster radius (R 0 ) of said pair ranging between 20 and 55 Å; (b) measuring the FRET signal in the absence and in the presence of the compound to be tested within a predetermined time window; (c) selecting the compound to be tested as a modulating compound if a difference in the FRET signal in the absence and in the presence of the compound to be tested is measured during step (b). The invention can be used in the research for new drugs and new taste modulators.
摘要:
The invention relates to a compound of formula (I):
wherein R 1 , R 2 , R 3 and R 4 are as defined in the description. The invention also relates to europium (III) complexes obtained from a compound of formula (I), or from a complexing agent including said compound, and to the use of such complexes to label organic or biological molecules.